64
Views
14
CrossRef citations to date
0
Altmetric
Original Article

The Treatment of Acute Lymphoblastic Leukaemia in the Elderly

, , &
Pages 117-123 | Received 25 Apr 2003, Published online: 03 Aug 2009

References

  • Sandler, D.P. and Ross, J.A. (1997) "Epidemiology of acute leukemia in children and adults", Seminars in Oncology 24, 3–16.
  • Taylor, P.R.A., Reid, M.M., Bown, N., Hamilton, P.J. and Proctor, S.J. (1992) "Acute lymphoblastic leukemia in patients aged 60 years and over: a population-based study of incidence and outcome", Blood, 80, 1813–1817.
  • Bernabei, R., Venturiero, V., Tarsitani, P. and Gambassi, G. (2000) "The comprehensive geriatric assessment: when, where, how", Critical Reviews in Oncology/ Hematology, 33, 45–56.
  • Taylor, P.R.A., Reid, M.M. and Proctor, S.J. (1994) "Acute lymphoblastic leukaemia in the elderly", Leukemia and Lymphoma, 13, 373 — 380.
  • Kantarjian, H.M., O'Brien, S., Smith, T., Estey, E.H., Beran, M., Preti, A., Pierce, S. and Keating, M.J. (1994) "Acute lymphocytic leukaemia in the elderly: characteristics and outcome with the vincristine-adriamycin-dexamethasone (VAD) regimen", British Journal of Haematology, 88, 94–100.
  • Pui, C.H. and Evans, W.E. (1998) "Acute lymphoblastic leukae-mia", New England Journal of Medicine, 339, 605–615.
  • Delannoy, A., Ferrant, A., Bosly, A., Chatelain, C., Doyen, C., Martiat, P., Michaux, J.L. and Sokal, G. (1990) "Acute lympho-blastic leukemia in the elderly", European Journal of Haematology, 45, 90–93.
  • Spath-Schwalbe, E., Heil, G. and Heimpel, H. (1994) "Acute lymphoblastic leukemia in patients over 59 years of age. Experience in a single center over a 10-year period", Annals of Hematology, 69, 291 — 296.
  • Ferrari, A., Annino, L., Crescenzi, S., Romani, C. and Mandelli, F. (1995) "Acute lymphoblastic leukemia in the elderly: results of two different treatment approaches in 49 patients during a 25-year period", Leukemia, 9, 1643 — 1647.
  • Bassan, R., Di Bona, E., Lerede, T., Pogliani, E., Rossi, G., D'Emilio, A., et al. (1996) "Age-adapted moderate-dose induction and flexible outpatient postremission therapy for elderly patients with acute lymphoblastic leukaemia", Leukemia and Lymphoma, 22, 295— 301.
  • Legrand, O., Marie, J.P., Marjanovic, Z., Cadiou, M., Blanc, C., Ramond, S., et al. (1997) "Prognostic factors in elderly acute lymphoblastic leukaemia", British Journal of Haematology, 97, 596— 602.
  • Mandelli, F., Annino, L., Vegna, M.L., Ferrari, A., Di Raimondo, F., Invernizzi, R., et al. (1997) "Treatment of acute lympho-blastic leukemia in the elderly: result of the GIMEMA ALL 0288 60 years trial". In Acute Leukemias VI. Prognostic factors and treatment strategies, edited by Buchner et al. 688— 694.
  • Delannoy, A., Sebban, C., Cony-Makhoul, P., Cazin, B., Cordonnier, C., Bouabdallah, R., et al. (1997) "Age-adapted induction treatment of acute lymphoblastic leukemia in the elderly and assessment of maintenance with interferon combined with chemotherapy. A multicentric prospective study in forty patients", Leukemia, 11, 1429–1434.
  • Nagura, E., Minami, S., Nagata, K., Morishita, Y., Takeyama, H., Sao, H., et al. (1999) "Analysis of elderly patients, aged 60 years old or over, with acute lymphoblastic leukaemia", Nippon Ronen Igakkai Zasshi, 36, 52— 58.
  • Pagano, L., Mele, L., Casorelli, I., Fianchi, L., Di Febo, A. and Leone, G. (2000) "Acute lymphoblastic leukemia in the elderly. A twelve-year single center, retrospective study", Haematologica, 85(12), 1327–1329.
  • Thomas, X., Olteanu, N., Charrin, C., Lheritier, V., Magaud, J.P. and Fiere, D. (2001) "Acute Lymphoblastic Leukemia inthe elderly: the Edouard Herriot Hospital experience", American Journal of Hematology, 67, 73–83.
  • Yenerel, M.N., Atamer, T., Yavuz, A.S., Kucukkaya, R., Besisik, S., Aktan, M., et al. (2002) "Myeloid antigen expression provides favorable outcome in patients with adult acute lymphoblastic leukemia: a single-center study", Annals of Hematology, 81, 498 — 503.
  • Kantarjian, H.M., O'Brien, S., Smith, T.L., Cortes, J., Giles, F.J., Beran, M., et al. (2000) "Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia", Journal of Clinical Oncology, 18, 547–561.
  • Secker-Walker, L.M., Prentice, H.G., Durrant, J., Richards, S., Hall, E. and Harrison, G. (1997) "Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukae-mia on MRC trial UKALL XA", MRC Adult Leukaemia Working Party, British Journal of Haematology, 97, 937–938.
  • Weztler, M., Dodge, R.K., Mr6zek, K., Carroll, A.J., Tantravahi, R., Block, A.M.W., et al. (1999) "Prospective karyotype analysis in adult acute lymphoblastic leukemia: the Cancer and Leukemia Group B Experience", Blood, 93, 3983–3993.
  • Coso, D., Cazin, B., Thomas, X., Boiron, J.M., Huguet, F., Zerazhi, H., et al. For The LALA Group, Hopital E. Herriot, Lyon, France. (2001) "Characteristics of Philadelphia-positive acute lymphocytic leukaemia (Ph + ALL) in the elderly", The American Society of Hematology, Orlando, Florida, 7— 11 December 2001. Abstract 1347.
  • Anonymous (1996) "Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. A collaborative study of the Group francais de Cytogenetique Hematologique", Blood, 87, 3135 — 3142.
  • Mandelli, F., Annino, L., Vegna, ML., Camera, A., Ciolli, S., Deplano, W., et al. (1992) "GIMEMA 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results", Leukemia, 6(Suppl 2), 182— 185.
  • Hussein, K.K., Dahlberg, S., Head, D., Waddell, CC., Dabich, L., Weick, J.K., et al. (1989) "Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and maintenance chemotherapy", Blood, 73, 57–63.
  • Hoelzer, D., Thiel, E., Loffler, H., Bodenstein, H., Plaumann, L., Buchner, T., et al. (1984) "Intensified therapy in acute lympho-blastic and acute undifferentiated leukemia in adults", Blood, 64, 38–47.
  • Delannoy, A., Cazin, B., Thomas, X., Bouabdallah, R., Boiron, J.M., Huguet, F., et al. (2002) "Treatment of acute lymphoblastic leukemia in the elderly: an evaluation of interferon alpha given as a single agent after complete remission", Leukemia and Lymphoma, 43, 75–81.
  • Offidani, M., Corvatta, L., Malerba, L., Mele, A., Catarini, M. and Leoni, P. (2000) "High-dose Daunorubicin as liposomal compound in patients with ALL older than 60 years", The American Society of Hematology, Blood, vol. 96, 11, Abstract 4650.
  • Zilvassy, S.J. and Cory, S. (1993) "Phenotypic and functional characterization of competitive long-term repopulating hemato-poietic stem cells enriched from 5-fluorouracil-treated murine marrow", Blood, 81, 2310–2320.
  • Zhou, D.C., Hoang-Ngoc, L., Delmer, A., Faussat, A.M., Russo, D., Zittoun, R. and Marie. J.P. (1994) "Expression of resistance genes in acute leukemia", Leukemia and Lymphoma, 13\(Suppl 1), 27— 30.
  • Schiedlmeier, B., Schilz, A.J., Kuhlcke, K., Laufs, S., Baum, C., Zeller, W.J., et al. (2002) "Multidrug resistance 1 gene transfer can confer chemoprotection to human peripheral blood progenitor cells engrafted in immunodeficient mice", Human Gene Therapy, 20, 233— 242.
  • Cortes, J., O'Brien, S., Estey, E., Giles, F., Keating, M. and Kantarjian, H. (1999) "Phase I study of liposomal daunorubicin in patients with acute leukaemia", Investigative New Drugs, 17, 81 — 87.
  • Tafuri, A., Amadori, S., Ferrara, F. et al. for the GIMEMA Cooperative Study Group. (1999) "A pilot GIMEMA study of liposomal daunorubicin plus cytosine arabinoside for elderly patients with acute myeloid leukaemia", Blood, 94\(Suppl 1), abstr 2270.
  • Estey, E. (1998) "Hematopoietic growth factors in the treatment of acute leukaemia", Current Opinion in Oncology, 10, 23— 30.
  • Thomas, D.A., Cortes, J., Giles, F., O'Brien, S., Faderl, S., Koller, C., et al. (2001) "The modified Hyper-CVAD regimen in newly diagnosed adult acute lymphoblastic leukemia (ALL)", American Society of Hematology, Orlando-Florida, 7–11 December, 2001 (Abstr 2474).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.